Title
Circadian and sleep dysfunction in Alzheimer's disease
Date Issued
01 July 2020
Access level
metadata only access
Resource Type
review
Author(s)
Uddin M.S.
Tewari D.
Mamun A.A.
Kabir M.T.
Niaz K.
Wahed M.I.I.
Ashraf G.M.
University of Limerick
Publisher(s)
Elsevier Ireland Ltd
Abstract
Alzheimer's disease (AD) is a devastating and irreversible cognitive impairment and the most common type of dementia. Along with progressive cognitive impairment, dysfunction of the circadian rhythms also plays a pivotal role in the progression of AD. A mutual relationship among circadian rhythms, sleep, and AD has been well-recommended. The etiopathogenesis of the disturbances of the circadian system and AD share some general features that also unlock the outlook of observing them as a mutually dependent pathway. Indeed, the burden of amyloid β (Aβ), neurofibrillary tangles (NFTs), neuroinflammation, oxidative stress, and dysfunction of circadian rhythms may lead to AD. Aging can alter both sleep timings and quality that can be strongly disrupted in AD. Increased production of Aβ and reduced Aβ clearance are caused by a close interplay of Aβ, sleep disturbance and raised wakefulness. Besides Aβ, the impact of tau pathology is possibly noteworthy to the sleep deprivation found in AD. Hence, this review is focused on the primary mechanistic complexities linked to disruption of circadian rhythms, sleep deprivation, and AD. Furthermore, this review also highlights the potential therapeutic strategies to abate AD pathogenesis.
Volume
60
Number
101046
Language
English
OCDE Knowledge area
Neurología clínica
Scopus EID
2-s2.0-85083255490
PubMed ID
Source
Ageing Research Reviews
ISSN of the container
15681637
Sponsor(s)
This project was supported by the Pharmakon Neuroscience Research Network, Dhaka, Bangladesh .
Sources of information: Directorio de Producción Científica Scopus